These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39393272)

  • 1. Comprehensive multi-omics analysis of the prognostic value and immune signature of NCF2 in pan-cancer and its relationship with acute myeloid leukemia.
    Zhong F; Zeng Y; Yan Y; Guo L; Guo Q; Liu W; Liu C
    Int Immunopharmacol; 2024 Dec; 143(Pt 1):113364. PubMed ID: 39393272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-omics evaluation of the prognostic value and immune signature of FCN1 in pan-cancer and its relationship with proliferation and apoptosis in acute myeloid leukemia.
    Zhong F; Song L; Li H; Liu J; Liu C; Guo Q; Liu W
    Front Genet; 2024; 15():1425075. PubMed ID: 39139822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD metabolism-related genes provide prognostic value and potential therapeutic insights for acute myeloid leukemia.
    Cao Y; Shu W; Jin P; Li J; Zhu H; Chen X; Zhu Y; Huang X; Cheng W; Shen Y
    Front Immunol; 2024; 15():1417398. PubMed ID: 38966636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of NCF2 as a potential prognostic factor and immune infiltration indicator in hepatocellular carcinoma.
    Huang N; Zhang J; Kuang S; Li Z; Zhao H; Wu J; Liu M; Wang L
    Cancer Med; 2023 Apr; 12(7):8991-9004. PubMed ID: 36680322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosome-related genes predict acute myeloid leukemia prognosis and response to immunotherapy.
    Wan P; Zhong L; Yu L; Shen C; Shao X; Chen S; Zhou Z; Wang M; Zhang H; Liu B
    Front Immunol; 2024; 15():1384633. PubMed ID: 38799454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive characterization of immunogenic cell death in acute myeloid leukemia revealing the association with prognosis and tumor immune microenvironment.
    Chen Y; Qiu X; Liu R
    BMC Med Genomics; 2024 Apr; 17(1):107. PubMed ID: 38671491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-cancer analysis of LRRC59 with a focus on prognostic and immunological roles in hepatocellular carcinoma.
    Pan B; Cheng J; Tan W; Wu X; Fan Q; Fan L; Jiang M; Yu R; Cheng X; Deng Y
    Aging (Albany NY); 2024 May; 16(9):8171-8197. PubMed ID: 38738999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of lnc-CRNDE presents as a biomarker for acute myeloid leukemia and promotes the malignant progression in acute myeloid leukemia cell line U937.
    Wang Y; Zhou Q; Ma JJ
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):763-770. PubMed ID: 29461608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RREB1 could act as an immunological and prognostic biomarker: From comprehensive analysis to osteosarcoma validation.
    Zhang Z; Liu B; Mei L; Chen R; Zhou H; Li Z
    Int Immunopharmacol; 2024 Dec; 143(Pt 1):113312. PubMed ID: 39405927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning-based biomarker screening for acute myeloid leukemia prognosis and therapy from diverse cell-death patterns.
    Qin Y; Pu X; Hu D; Yang M
    Sci Rep; 2024 Aug; 14(1):17874. PubMed ID: 39090256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognostic and Immune Significance of BZW2 in Pan-Cancer and its Relationship with Proliferation and Apoptosis of Cervical Cancer.
    Li C; Li Q; Li L; Sun S; Lei X
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):97. PubMed ID: 38538258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of an immune-related prognostic signature and lncRNA-miRNA-mRNA ceRNA network in acute myeloid leukemia.
    Qin L; Li B; Wang S; Tang Y; Fahira A; Kou Y; Li T; Hu Z; Huang Z
    J Leukoc Biol; 2024 Jun; 116(1):146-165. PubMed ID: 38393298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-omics landscape of Interferon-stimulated gene OASL reveals a potential biomarker in pan-cancer: from prognosis to tumor microenvironment.
    Liu Y; Yang R; Zhang M; Yang B; Du Y; Feng H; Wang W; Xue B; Niu F; He P
    Front Immunol; 2024; 15():1402951. PubMed ID: 39286258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-related gene signature predicts clinical outcomes and immunotherapy response in acute myeloid leukemia.
    Xu Q; Cao D; Fang B; Yan S; Hu Y; Guo T
    Cancer Med; 2022 Sep; 11(17):3364-3380. PubMed ID: 35355427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple omics integrative analysis identifies GARS1 as a novel prognostic and immunological biomarker: from pan-cancer to bladder cancer.
    Liu W; Wei C; He Q; Chen Z; Zhuang W; Guo Y; Xue X
    Sci Rep; 2024 Aug; 14(1):19025. PubMed ID: 39152248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8 + T cell-based molecular subtypes with heterogeneous immune landscapes and clinical significance in acute myeloid leukemia.
    Zhong F; Yao F; Jiang J; Yu X; Liu J; Huang B; Wang X
    Inflamm Res; 2024 Mar; 73(3):329-344. PubMed ID: 38195768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of PPP4C's impact on prognosis, immune microenvironment, and immunotherapy response in lung adenocarcinoma using single-cell sequencing and multi-omics.
    Wang K; Peng B; Xu R; Lu T; Chang X; Shen Z; Shi J; Li M; Wang C; Zhou X; Xu C; Chang H; Zhang L
    Front Immunol; 2024; 15():1416632. PubMed ID: 39026674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCK is a Potential Prognostic Biomarker that Correlates with Immune Cell Infiltration in Acute Myeloid Leukemia.
    Cheng F; Li Q; Wang J; Wang L; Li W; Zeng F
    Dis Markers; 2022; 2022():3199589. PubMed ID: 35280440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype.
    Liu Y; Chen Y; Liu Y; Li M; Zhang Y; Shi L; Yang L; Li T; Li Y; Jiang Z; Liu Y; Wang C; Wang S
    J Transl Med; 2022 Dec; 20(1):612. PubMed ID: 36550462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the Integrated Prognostic Signature Associated with Immuno-relevant Genes and Long Non-coding RNAs in Acute Myeloid Leukemia.
    Zhao C; Wang Y; Sharma A; Wang Z; Zheng C; Wei Y; Wu Y; Liu P; Liu J; Zhan X; Schmidt-Wolf I; Tu F
    Cancer Invest; 2022 Sep; 40(8):663-674. PubMed ID: 35770858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.